RTX

Take This Into Account Before Investing in RTX

Large-cap Industrials company Raytheon Technologies moved -0.6% Friday on a volume of 4,568,300, compared to its average of 4,246,611.

Raytheon Technologies trades -11.03% away from its average analyst target price of $109.5 per share. The 20 analysts following the stock have set target prices ranging from $98.0 to $120.0, and on average have given Raytheon Technologies a rating of buy.

If you are considering an investment in RTX, you'll want to know the following:

  • Raytheon Technologies's current price is 83.0% above its Graham number of $53.24, which implies that at its current valuation it does not offer a margin of safety

  • Based on its trailing earnings per share of 3.75, Raytheon Technologies has a trailing 12 month Price to Earnings (P/E) ratio of 26.0 while the S&P 500 average is 15.97

  • RTX has a forward P/E ratio of 16.9 based on its forward 12 month price to earnings (EPS) of $5.76 per share

  • The company has a price to earnings growth (PEG) ratio of 1.81 — a number near or below 1 signifying that Raytheon Technologies is fairly valued compared to its estimated growth potential

  • Its Price to Book (P/B) ratio is 1.96 compared to its sector average of 3.78

  • Raytheon Technologies Corporation, an aerospace and defense company, provides systems and services for the commercial, military, and government customers worldwide.

  • Based in Arlington, the company has 182,000 full time employees and a market cap of $142.34 Billion. Raytheon Technologies currently returns an annual dividend yield of 2.2%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS